77 related articles for article (PubMed ID: 1695189)
21. Insulin levels and glucose intolerance in patients with cirrhosis and non cirrhotic portal fibrosis.
Vij JC; Gaur SK; Sharma SK; Yadav HS; Kumar N; Anand BS
J Assoc Physicians India; 1987 Jul; 35(7):479-82. PubMed ID: 3323185
[No Abstract] [Full Text] [Related]
22. [Serum concentration of bile acids and portal hypertension in cirrhotic patients. Possible correlations].
Tarantino G; Cambri S; Ferrara A; Marzano M; Liberti A; Vellone G; Ciccarelli AF
Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):195-205. PubMed ID: 2640042
[TBL] [Abstract][Full Text] [Related]
23. Plasma endothelin-1 level as a marker reflecting the severity of portal hypertension in biliary atresia.
Hasegawa T; Kimura T; Sasaki T; Okada A
J Pediatr Surg; 2001 Nov; 36(11):1609-12. PubMed ID: 11685683
[TBL] [Abstract][Full Text] [Related]
24. [Characteristics of thrombocyte aggregation properties in portal hypertension syndrome complicated by esophagogastric hemorrhage].
Lytkin MI; Didenko VM; Tulupov AN; Kotiv BN; Khokhlov AV
Vestn Khir Im I I Grek; 1989 Oct; 143(10):25-9. PubMed ID: 2631347
[TBL] [Abstract][Full Text] [Related]
25. Plasma catecholamines in patients with presinusoidal portal hypertension: comparison with cirrhotic patients and nonportal hypertensive subjects.
Gaudin C; Braillon A; Poo JL; Kleber G; Moreau R; Lebrec D
Hepatology; 1991 May; 13(5):913-6. PubMed ID: 2029995
[TBL] [Abstract][Full Text] [Related]
26. Consumption coagulopathy in liver cirrhosis.
Hörder MH
Thromb Diath Haemorrh Suppl; 1969; 36():313-8. PubMed ID: 5375546
[No Abstract] [Full Text] [Related]
27. [Pre- and postoperative correction of hyposiderosis in surgical treatment of portal hypertension].
Musalatov KhA; Gordeev PS; Mindadze NA
Khirurgiia (Mosk); 1998; (5):18-20. PubMed ID: 9642953
[TBL] [Abstract][Full Text] [Related]
28. Fibronectin decrease in liver cirrhosis is related to spleen size.
de Angelis V; Zambon M; Toffolo L; Donada C; Molaro GL; Zuin R
Klin Wochenschr; 1988 Jun; 66(12):524-6. PubMed ID: 3419082
[TBL] [Abstract][Full Text] [Related]
29. [Surgical treatment of portal hypertension in patients with liver cirrhosis].
D'Albuquerque LA; de Oliveira e Silva A; Pinto Júnior PE; de Miranda MP; Genzini T; Gama-Rodrigues JJ
Arq Gastroenterol; 1988; 25(4):218-23. PubMed ID: 3077244
[TBL] [Abstract][Full Text] [Related]
30. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
Stein SF; Harker LA
J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
[TBL] [Abstract][Full Text] [Related]
31. Early enteral and parenteral nutritional support in patients with cirrhotic portal hypertension after pericardial devascularization.
Zhang K; Sun WB; Wang HF; Li ZW; Zhang XD; Wang HB; Ji X
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):55-9. PubMed ID: 15730920
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
[TBL] [Abstract][Full Text] [Related]
33. Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis.
Sato Y; Kobayashi T; Nakatsuka H; Yamamoto S; Oya H; Watanabe T; Hatakeyama K
Hepatogastroenterology; 2001; 48(39):831-5. PubMed ID: 11462934
[TBL] [Abstract][Full Text] [Related]
34. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
Tomihira M
Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
[TBL] [Abstract][Full Text] [Related]
35. Liver cirrhosis: an unfavorable factor for nonoperative management of blunt splenic injury.
Fang JF; Chen RJ; Lin BC; Hsu YB; Kao JL; Chen MF
J Trauma; 2003 Jun; 54(6):1131-6; discussion 1136. PubMed ID: 12813334
[TBL] [Abstract][Full Text] [Related]
36. [Implications of the arterialization of the sinusoid in its capillarization and in the maintenance of portal hypertension in the cirrhotic patient].
Ceña Lázaro G; Barrao Comps F; Omiste Martínez JL; Ducóns García J; Rojo Puente S; Laquidaín Hergueta M; Bueno Gómez J
Rev Esp Enferm Apar Dig; 1987 Feb; 71(2):111-3. PubMed ID: 3563042
[No Abstract] [Full Text] [Related]
37. [Laparoscopic splenectomy and pericardial devascularization for treatment of portal hypertension due to liver cirrhosis].
Hong DF; Zheng XY; Peng SY; Gao M; Wu JG; Cao Q
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):820-2. PubMed ID: 17565864
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic importance of fibronectin in chronic liver diseases].
Golubović M; Majkić-Singh N; Marković S; Sumarac Z; Obradović I
Med Pregl; 1999; 52(1-2):35-8. PubMed ID: 10352502
[TBL] [Abstract][Full Text] [Related]
39. Disordered hemostasis in extrahepatic portal hypertension.
Robson SC; Kahn D; Kruskal J; Bird AR; Kirsch RE
Hepatology; 1993 Oct; 18(4):853-7. PubMed ID: 8406359
[TBL] [Abstract][Full Text] [Related]
40. Estrogens and portal hypertension in cirrhosis of the liver.
Gluud C; Henriksen HH; Svenstrup B
N Engl J Med; 1981 Jan; 304(1):52. PubMed ID: 7432439
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
